{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T16:24:01Z","timestamp":1791822241508,"version":"4.3.4"},"reference-count":58,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2018,7,9]],"date-time":"2018-07-09T00:00:00Z","timestamp":1531094400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100008530","name":"European Regional Development Fund","doi-asserted-by":"publisher","award":["PI2017\/04-3"],"award-info":[{"award-number":["PI2017\/04-3"]}],"id":[{"id":"10.13039\/501100008530","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008530","name":"European Regional Development Fund","doi-asserted-by":"publisher","award":["P_37_732\/2016 REDBRAIN"],"award-info":[{"award-number":["P_37_732\/2016 REDBRAIN"]}],"id":[{"id":"10.13039\/501100008530","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Redox Biology"],"published-print":{"date-parts":[[2018,9]]},"DOI":"10.1016\/j.redox.2018.07.006","type":"journal-article","created":{"date-parts":[[2018,7,11]],"date-time":"2018-07-11T13:34:48Z","timestamp":1531316088000},"page":"173-180","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":113,"special_numbering":"C","title":["Deficiency in the transcription factor NRF2 worsens inflammatory parameters in a mouse model with combined tauopathy and amyloidopathy"],"prefix":"10.1016","volume":"18","author":[{"given":"Ana I.","family":"Rojo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Pajares","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angel J.","family":"Garc\u00eda-Yag\u00fce","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Izaskun","family":"Buendia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fred","family":"Van Leuven","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masayuki","family":"Yamamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuela G.","family":"L\u00f3pez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Cuadrado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.redox.2018.07.006_bib1","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1111\/j.1471-4159.2004.02743.x","article-title":"Non-steroidal anti-inflammatory drugs (NSAIDs) in Alzheimer's disease: old and new mechanisms of action","volume":"91","author":"Gasparini","year":"2004","journal-title":"J. Neurochem."},{"key":"10.1016\/j.redox.2018.07.006_bib2","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.1212\/01.wnl.0000311269.57716.63","article-title":"Protective effects of NSAIDs on the development of Alzheimer disease","volume":"70","author":"Vlad","year":"2008","journal-title":"Neurology"},{"key":"10.1016\/j.redox.2018.07.006_bib3","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1056\/NEJMoa010178","article-title":"Nonsteroidal antiinflammatory drugs and the risk of Alzheimer's disease","volume":"345","author":"in t\u2032 Veld","year":"2001","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.redox.2018.07.006_bib4","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1093\/aje\/kwi029","article-title":"Meta-analysis of nonsteroidal antiinflammatory drug use and risk of dementia","volume":"161","author":"de Craen","year":"2005","journal-title":"Am. J. Epidemiol."},{"key":"10.1016\/j.redox.2018.07.006_bib5","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1212\/WNL.58.7.1050","article-title":"Randomized pilot study of nimesulide treatment in Alzheimer's disease","volume":"58","author":"Aisen","year":"2002","journal-title":"Neurology"},{"key":"10.1016\/j.redox.2018.07.006_bib6","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1212\/WNL.43.8.1609","article-title":"Clinical trial of indomethacin in Alzheimer's disease","volume":"43","author":"Rogers","year":"1993","journal-title":"Neurology"},{"key":"10.1016\/j.redox.2018.07.006_bib7","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1212\/WNL.62.1.66","article-title":"Protocol 091 Study, Rofecoxib: no effect on Alzheimer's disease in a 1-year, randomized, blinded, controlled study","volume":"62","author":"Reines","year":"2004","journal-title":"Neurology"},{"key":"10.1016\/j.redox.2018.07.006_bib8","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1212\/WNL.53.1.197","article-title":"A double-blind, placebo-controlled trial of diclofenac\/misoprostol in Alzheimer's disease","volume":"53","author":"Scharf","year":"1999","journal-title":"Neurology"},{"key":"10.1016\/j.redox.2018.07.006_bib9","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1002\/glia.20947","article-title":"Nrf2 regulates microglial dynamics and neuroinflammation in experimental Parkinson's disease","volume":"58","author":"Rojo","year":"2010","journal-title":"Glia"},{"key":"10.1016\/j.redox.2018.07.006_bib10","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1093\/brain\/awt323","article-title":"Fractalkine activates NRF2\/NFE2L2 and heme oxygenase 1 to restrain tauopathy-induced microgliosis","volume":"137","author":"Lastres-Becker","year":"2014","journal-title":"Brain: J. Neurol."},{"key":"10.1016\/j.redox.2018.07.006_bib11","doi-asserted-by":"crossref","first-page":"1766","DOI":"10.1089\/ars.2013.5745","article-title":"Redox control of microglial function: molecular mechanisms and functional significance","volume":"21","author":"Rojo","year":"2014","journal-title":"Antioxid. Redox Signal."},{"key":"10.1016\/j.redox.2018.07.006_bib12","doi-asserted-by":"crossref","first-page":"78ra32","DOI":"10.1126\/scitranslmed.3002042","article-title":"Targeting Nrf2 signaling improves bacterial clearance by alveolar macrophages in patients with COPD and in a mouse model","volume":"3","author":"Harvey","year":"2011","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.redox.2018.07.006_bib13","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1016\/j.redox.2014.04.008","article-title":"Redox status in mammalian cells and stem cells during culture in vitro: critical roles of Nrf2 and cystine transporter activity in the maintenance of redox balance","volume":"2","author":"Ishii","year":"2014","journal-title":"Redox Biol."},{"key":"10.1016\/j.redox.2018.07.006_bib14","doi-asserted-by":"crossref","first-page":"2348","DOI":"10.1016\/j.celrep.2016.07.075","article-title":"Nrf2 induces IL-17D to mediate tumor and virus surveillance","volume":"16","author":"Saddawi-Konefka","year":"2016","journal-title":"Cell Rep."},{"key":"10.1016\/j.redox.2018.07.006_bib15","doi-asserted-by":"crossref","first-page":"11624","DOI":"10.1038\/ncomms11624","article-title":"Nrf2 suppresses macrophage inflammatory response by blocking proinflammatory cytokine transcription","volume":"7","author":"Kobayashi","year":"2016","journal-title":"Nat. Commun."},{"key":"10.1016\/j.redox.2018.07.006_bib16","doi-asserted-by":"crossref","first-page":"4328","DOI":"10.1073\/pnas.88.10.4328","article-title":"Modulation of transcription factor NF-kappa B binding activity by oxidation-reduction in vitro","volume":"88","author":"Toledano","year":"1991","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.redox.2018.07.006_bib17","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1038\/cr.2010.178","article-title":"Crosstalk of reactive oxygen species and NF-kappaB signaling","volume":"21","author":"Morgan","year":"2011","journal-title":"Cell Res."},{"key":"10.1016\/j.redox.2018.07.006_bib18","doi-asserted-by":"crossref","first-page":"15244","DOI":"10.1074\/jbc.M113.540633","article-title":"Transcription factors NRF2 and NF-kappaB are coordinated effectors of the Rho family, GTP-binding protein RAC1 during inflammation","volume":"289","author":"Cuadrado","year":"2014","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.redox.2018.07.006_bib19","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1089\/ars.2005.7.889","article-title":"NF-kappaB, Nrf2, and HO-1 interplay in redox-regulated VCAM-1 expression","volume":"7","author":"Banning","year":"2005","journal-title":"Antioxid. Redox Signal."},{"key":"10.1016\/j.redox.2018.07.006_bib20","doi-asserted-by":"crossref","first-page":"3437","DOI":"10.1093\/eurheartj\/ehv544","article-title":"Heme oxygenase-1 suppresses a pro-inflammatory phenotype in monocytes and determines endothelial function and arterial hypertension in mice and humans","volume":"36","author":"Wenzel","year":"2015","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.redox.2018.07.006_bib21","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1002\/jcb.22155","article-title":"Redox-sensitive regulation of gene expression in human primary macrophages exposed to inorganic arsenic","volume":"107","author":"Bourdonnay","year":"2009","journal-title":"J. Cell Biochem."},{"key":"10.1016\/j.redox.2018.07.006_bib22","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1111\/acel.12078","article-title":"Declining signal dependence of Nrf2-MafS-regulated gene expression correlates with aging phenotypes","volume":"12","author":"Rahman","year":"2013","journal-title":"Aging Cell"},{"key":"10.1016\/j.redox.2018.07.006_bib23","doi-asserted-by":"crossref","first-page":"3381","DOI":"10.1073\/pnas.0400282101","article-title":"Decline in transcriptional activity of Nrf2 causes age-related loss of glutathione synthesis, which is reversible with lipoic acid","volume":"101","author":"Suh","year":"2004","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.redox.2018.07.006_bib24","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1172\/JCI64096","article-title":"Causes, consequences, and reversal of immune system aging","volume":"123","author":"Montecino-Rodriguez","year":"2013","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.redox.2018.07.006_bib25","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1038\/nature20411","article-title":"Ageing, neurodegeneration and brain rejuvenation","volume":"539","author":"Wyss-Coray","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.redox.2018.07.006_bib26","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/1471-2350-11-36","article-title":"Association of Nrf2-encoding NFE2L2 haplotypes with Parkinson's disease","volume":"11","author":"von Otter","year":"2010","journal-title":"BMC Med. Genet."},{"key":"10.1016\/j.redox.2018.07.006_bib27","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.mad.2009.12.007","article-title":"Nrf2-encoding NFE2L2 haplotypes influence disease progression but not risk in Alzheimer's disease and age-related cataract","volume":"131","author":"von Otter","year":"2010","journal-title":"Mech. Ageing Dev."},{"key":"10.1016\/j.redox.2018.07.006_bib28","doi-asserted-by":"crossref","first-page":"130","DOI":"10.3109\/21678421.2013.839708","article-title":"Association of NFE2L2 and KEAP1 haplotypes with amyotrophic lateral sclerosis","volume":"15","author":"Bergstrom","year":"2014","journal-title":"Amyotroph. Lateral Scler. Frontotemp. Degener."},{"key":"10.1016\/j.redox.2018.07.006_bib29","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1186\/s12881-014-0131-4","article-title":"Genetic associations of Nrf2-encoding NFE2L2 variants with Parkinson's disease - a multicenter study","volume":"15","author":"von Otter","year":"2014","journal-title":"BMC Med. Genet."},{"key":"10.1016\/j.redox.2018.07.006_bib30","doi-asserted-by":"crossref","first-page":"16505","DOI":"10.1073\/pnas.0908397106","article-title":"Intrahippocampal injection of a lentiviral vector expressing Nrf2 improves spatial learning in a mouse model of Alzheimer's disease","volume":"106","author":"Kanninen","year":"2009","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.redox.2018.07.006_bib31","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1016\/j.neurobiolaging.2014.09.004","article-title":"Increased Alzheimer's disease-like pathology in the APP\/ PS1DeltaE9 mouse model lacking Nrf2 through modulation of autophagy","volume":"36","author":"Joshi","year":"2015","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.redox.2018.07.006_bib32","doi-asserted-by":"crossref","first-page":"3496","DOI":"10.1038\/ncomms4496","article-title":"Nrf2 reduces levels of phosphorylated tau protein by inducing autophagy adaptor protein NDP52","volume":"5","author":"Jo","year":"2014","journal-title":"Nat. Commun."},{"key":"10.1016\/j.redox.2018.07.006_bib33","doi-asserted-by":"crossref","DOI":"10.1042\/AN20100033","article-title":"The anti-inflammatory effects of dimethyl fumarate in astrocytes involve glutathione and haem oxygenase-1","volume":"3","author":"Lin","year":"2011","journal-title":"ASN Neuro"},{"key":"10.1016\/j.redox.2018.07.006_bib34","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1124\/jpet.111.190132","article-title":"Fumarates promote cytoprotection of central nervous system cells against oxidative stress via the nuclear factor (erythroid-derived 2)-like 2 pathway","volume":"341","author":"Scannevin","year":"2012","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.redox.2018.07.006_bib35","doi-asserted-by":"crossref","first-page":"4777","DOI":"10.1073\/pnas.1603907113","article-title":"Dimethyl fumarate treatment induces adaptive and innate immune modulation independent of Nrf2","volume":"113","author":"Schulze-Topphoff","year":"2016","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.redox.2018.07.006_bib36","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1093\/brain\/awq386","article-title":"Fumaric acid esters exert neuroprotective effects in neuroinflammation via activation of the Nrf2 antioxidant pathway","volume":"134","author":"Linker","year":"2011","journal-title":"Brain: J. Neurol."},{"key":"10.1016\/j.redox.2018.07.006_bib37","doi-asserted-by":"crossref","first-page":"5","DOI":"10.3389\/fneur.2018.00005","article-title":"Emerging Understanding of the mechanism of action for dimethyl fumarate in the treatment of multiple sclerosis","volume":"9","author":"Mills","year":"2018","journal-title":"Front. Neurol."},{"key":"10.1016\/j.redox.2018.07.006_bib38","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1006\/bbrc.1997.6943","article-title":"An Nrf2\/small Maf heterodimer mediates the induction of phase II detoxifying enzyme genes through antioxidant response elements","volume":"236","author":"Itoh","year":"1997","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.redox.2018.07.006_bib39","doi-asserted-by":"crossref","first-page":"6483","DOI":"10.1074\/jbc.274.10.6483","article-title":"Early phenotypic changes in transgenic mice that overexpress different mutants of amyloid precursor protein in brain","volume":"274","author":"Moechars","year":"1999","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.redox.2018.07.006_bib40","doi-asserted-by":"crossref","first-page":"3963","DOI":"10.1074\/jbc.M409876200","article-title":"Changed conformation of mutant Tau-P301L underlies the moribund tauopathy, absent in progressive, nonlethal axonopathy of Tau-4R\/2N transgenic mice","volume":"280","author":"Terwel","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.redox.2018.07.006_bib41","doi-asserted-by":"crossref","DOI":"10.3791\/1787","article-title":"A simple composite phenotype scoring system for evaluating mouse models of cerebellar ataxia","author":"Guyenet","year":"2010","journal-title":"J. Vis. Exp."},{"key":"10.1016\/j.redox.2018.07.006_bib42","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/j.freeradbiomed.2011.11.003","article-title":"Signaling pathways activated by the phytochemical nordihydroguaiaretic acid contribute to a Keap1-independent regulation of Nrf2 stability: role of glycogen synthase kinase-3","volume":"52","author":"Rojo","year":"2012","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.redox.2018.07.006_bib43","doi-asserted-by":"crossref","first-page":"1902","DOI":"10.1080\/15548627.2016.1208889","article-title":"Transcription factor NFE2L2\/NRF2 is a regulator of macroautophagy genes","volume":"12","author":"Pajares","year":"2016","journal-title":"Autophagy"},{"key":"10.1016\/j.redox.2018.07.006_bib44","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1016\/j.redox.2017.07.006","article-title":"NRF2 deficiency replicates transcriptomic changes in Alzheimer's patients and worsens APP and TAU pathology","volume":"13","author":"Rojo","year":"2017","journal-title":"Redox Biol."},{"key":"10.1016\/j.redox.2018.07.006_bib45","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1089\/ars.2015.6549","article-title":"Repurposing the NRF2 activator dimethyl fumarate as therapy against synucleinopathy in Parkinson's disease","volume":"25","author":"Lastres-Becker","year":"2016","journal-title":"Antioxid. Redox Signal."},{"key":"10.1016\/j.redox.2018.07.006_bib46","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1038\/78078","article-title":"Neurofibrillary tangles, amyotrophy and progressive motor disturbance in mice expressing mutant (P301L) tau protein","volume":"25","author":"Lewis","year":"2000","journal-title":"Nat. Genet."},{"key":"10.1016\/j.redox.2018.07.006_bib47","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.nbd.2014.03.016","article-title":"Phosphorylation of protein Tau by GSK3beta prolongs survival of bigenic Tau.P301LxGSK3beta mice by delaying brainstem tauopathy","volume":"67","author":"Crespo-Biel","year":"2014","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.redox.2018.07.006_bib48","doi-asserted-by":"crossref","first-page":"45","DOI":"10.14802\/jmd.17066","article-title":"PSEN1 p.Met233Val in a complex neurodegenerative movement and neuropsychiatric disorder","volume":"11","author":"Appel-Cresswell","year":"2018","journal-title":"J. Mov. Disord."},{"key":"10.1016\/j.redox.2018.07.006_bib49","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1038\/nm1096-1146","article-title":"The E280A presenilin 1 Alzheimer mutation produces increased A beta 42 deposition and severe cerebellar pathology","volume":"2","author":"Lemere","year":"1996","journal-title":"Nat. Med."},{"key":"10.1016\/j.redox.2018.07.006_bib50","doi-asserted-by":"crossref","first-page":"1810","DOI":"10.1523\/JNEUROSCI.5261-09.2010","article-title":"Upper airway dysfunction of Tau-P301L mice correlates with tauopathy in midbrain and ponto-medullary brainstem nuclei","volume":"30","author":"Dutschmann","year":"2010","journal-title":"J. Neurosci."},{"key":"10.1016\/j.redox.2018.07.006_bib51","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.resp.2011.06.030","article-title":"Raphe tauopathy alters serotonin metabolism and breathing activity in terminal Tau.P301L mice: possible implications for tauopathies and Alzheimer's disease","volume":"178","author":"Menuet","year":"2011","journal-title":"Respir. Physiol. Neurobiol."},{"key":"10.1016\/j.redox.2018.07.006_bib52","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.nbd.2012.01.012","article-title":"Isoflurane anesthesia precipitates tauopathy and upper airways dysfunction in pre-symptomatic Tau.P301L mice: possible implication for neurodegenerative diseases","volume":"46","author":"Menuet","year":"2012","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.redox.2018.07.006_bib53","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1111\/j.1474-9726.2010.00658.x","article-title":"Accelerated aging phenotype in mice with conditional deficiency for mitochondrial superoxide dismutase in the connective tissue","volume":"10","author":"Treiber","year":"2011","journal-title":"Aging Cell"},{"key":"10.1016\/j.redox.2018.07.006_bib54","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/1742-2094-7-30","article-title":"Dimethylfumarate inhibits microglial and astrocytic inflammation by suppressing the synthesis of nitric oxide, IL-1beta, TNF-alpha and IL-6 in an in-vitro model of brain inflammation","volume":"7","author":"Wilms","year":"2010","journal-title":"J. Neuroinflamm."},{"key":"10.1016\/j.redox.2018.07.006_bib55","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1186\/1742-2094-9-163","article-title":"Effects of dimethyl fumarate on neuroprotection and immunomodulation","volume":"9","author":"Albrecht","year":"2012","journal-title":"J. Neuroinflamm."},{"key":"10.1016\/j.redox.2018.07.006_bib56","doi-asserted-by":"crossref","first-page":"e16172","DOI":"10.1371\/journal.pone.0016172","article-title":"Efficacy of fumaric acid esters in the R6\/2 and YAC128 models of Huntington's disease","volume":"6","author":"Ellrichmann","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.redox.2018.07.006_bib57","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.bbr.2016.04.012","article-title":"Dimethyl fumarate attenuates intracerebroventricular streptozotocin-induced spatial memory impairment and hippocampal neurodegeneration in rats","volume":"308","author":"Majkutewicz","year":"2016","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.redox.2018.07.006_bib58","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1126\/science.aan4665","article-title":"Dimethyl fumarate targets GAPDH and aerobic glycolysis to modulate immunity","volume":"360","author":"Kornberg","year":"2018","journal-title":"Science"}],"container-title":["Redox Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213231718304191?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213231718304191?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T06:05:21Z","timestamp":1761977121000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213231718304191"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9]]},"references-count":58,"alternative-id":["S2213231718304191"],"URL":"https:\/\/doi.org\/10.1016\/j.redox.2018.07.006","relation":{},"ISSN":["2213-2317"],"issn-type":[{"value":"2213-2317","type":"print"}],"subject":[],"published":{"date-parts":[[2018,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Deficiency in the transcription factor NRF2 worsens inflammatory parameters in a mouse model with combined tauopathy and amyloidopathy","name":"articletitle","label":"Article Title"},{"value":"Redox Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.redox.2018.07.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}